FDA issues guidance on antibiotics for cIAI

FDA issued draft guidance on the development of drugs to treat complicated intra-abdominal infection (cIAI). The agency recommended the use of active-controlled, non-inferiority Phase

Read the full 243 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE